Synthetic Blood Announces Department Of Defense Grant For Traumatic Brain Injury Clinical Trial With Oxycyte

Synthetic Blood International, Inc. (OTCBB:SYBD) announced that The United States Department of Defense (DoD) has approved the award of a $1.9 million grant to M. Ross Bullock, M.D., Ph.D., of the University of Miami Miller School of Medicine, Department of Neurosurgery and principal investigator for the Company’s planned Phase IIb clinical trial with Oxycyte? for the treatment of traumatic brain injury (TBI).

More: continued here

Filed under: Neurology / Neuroscience on February 27th, 2008